Respiratory Devices Market
Respiratory Devices Market by Product, End Users, & Region | Forecast 2023 to 2033
Today, Respiratory Illnesses and Diseases Affect Over 300 Million Individuals Worldwide, And The Figure Keeps Rising Every Year Future Market Insights, Inc To Provide Solutions For Future Respiratory Ailments!
Respiratory Devices Market Outlook (2023 to 2033)
The respiratory devices market size is projected to be valued at US$ 24.2 Billion in 2023 and is expected to rise to US$ 55.9 Billion by 2033. The sales of respiratory devices are expected to grow at a significant CAGR of 8.7% during the forecast period.
Various Key Factors Propelling The Demand For Respiratory Devices Are:
- The key causes propelling the market's expansion include the rising incidence of respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, and tuberculosis. For instance, the Global Initiative for Chronic Obstruction Disease's 2018 study estimates that by 2030, COPD will be responsible for 4.5 million annual deaths worldwide.
- The need for respiratory devices is also being impacted by the rising rate of preterm births and the rising elderly population. Both elderly people and premature newborns frequently have weakened immune systems, necessitating the use of various breathing support devices to enable artificial breathing and prevent respiratory illnesses.
- In recent years, home healthcare gadgets have grown in acceptance and market share. An additional area of interest for both established international manufacturers and other emerging suppliers is the introduction of therapeutic respiratory equipment for home healthcare.
- A favorable picture for the market is also being produced by significant efforts made by the government and non-governmental organizations (NGOs) to make high-quality healthcare services available to everyone as well as by establishing new and strengthening the current healthcare infrastructure.
| Attributes | Details |
|---|---|
|
Respiratory Devices Market CAGR |
8.7% |
|
Respiratory Devices Market Valuation (2023) |
US$ 24.2 Billion |
|
Respiratory Devices Market Valuation (2033) |
US$ 55.9 Billion |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
What is Future Outlook for Respiratory Devices Market in Comparison to the Historical Pattern?
According to the World Health Organization (WHO), Chronic Obstructive Pulmonary Disease (COPD) is a major health concern and is one of the leading causes of death globally. Technologically advanced medical devices and effective drugs have become key to the management of COPD and other respiratory disorders.
For instance, in 2016, the United Nations created Sustainable Development Goals (SDG) to improve living standards across the world. Similarly, the Forum of International Respiratory Societies (FIRS) was developed to address the soaring burdens of respiratory disorders. These efforts play important role in increasing demand for respiratory devices. According to Future Market Insights, Inc’s analysis, respiratory device sales have grown at 8.7% CAGR between 2022 and 2033.
Several new drugs were launched for the management of COPD and other respiratory diseases such as asthma over the last decade. With the number of products in the pipeline increasing, the Respiratory Devices Market will have greater scope for expansion especially as the demand for respiratory devices has surged amid the COVID-19 outbreak.
The pandemic crisis has led to fast-track drug approval and product launch and is the most trending among pharmaceutical manufacturers. COVID-19 has resulted in alliances between healthcare and non-healthcare industries to manufacture respiratory devices.
Manufacturers are producing increased quantities of respiratory devices to meet growing demand. These developments present a positive aspect of growth. Future Market Insights, Inc expects the global respiratory devices market to grow at 8.7% CAGR through 2033.
How are Combination Therapies Influencing Respiratory Devices Sales?
The use of combination therapies for the treatment of COPD and asthma has grown continuously. Patients are preferring combined therapies due to its advantages such as increased efficacy, more reliability in complex patients, and favorable reimbursement policies related to therapy. The increasing preference for combination therapies such as triple combination therapy is a key factor for respiratory device manufacturers.
Combination therapies are considered a reliable source of treatment for patients with complex respiratory disorders. Besides this, favorable reimbursement schemes have been encouraging the usage of these therapies.
Find your sweet spots for generating winning opportunities in this market.
How Will the Adoption of Portable Respiratory Devices Aid Growth?
Technology plays a key role in raising the bar for inhalers and nebulizers by improving the quality and increasing the ease of use of these devices. This would ultimately increase patient compliance. The advantages of portable devices such as lightweight, small shape, and ease to carry drive the adoption of these devices. Patients suffering from chronic respiratory diseases require a continuous oxygen supply. A portable oxygen concentrator has several other benefits which make it the best choice of device. Portable oxygen concentrators can be the future oxygen delivery device for toddlers.
A combination of cell phones and respiratory devices such as spirometers, and pulse oximeters, insists doctors access telemedicine services and data easily. Government initiatives for use of spirometer devices and the rising prevalence of chronic diseases are expected to create demand in top regions.
Some of the leading Respiratory Devices Market players are aiming at launching portable devices. For instance, in July 2022, OMRON Healthcare, the company's healthcare branch, unveiled its most recent oxygen delivery system, the OMRON medical molecular sieve-based oxygen concentrator. Pressure Swing Adsorption (PSA) technology is used by the portable device to deliver high-purity (>90%) oxygen at a rate of 5 liters per minute while removing unwelcome airborne molecules like nitrogen and argon.
What is the Impact of Regulations on Respiratory Devices Sale?
According to the World Health Organization (WHO) forecast, COPD will become the third leading cause of death across the world by 2025. The rising prevalence of respiratory ailments and the increasing demand for effective treatment have been surging growth opportunities. With the implementation of favorable reimbursement policies, the Respiratory Devices Market is expected to gain remarkable growth in the new few years.
Improvements in the government healthcare system and a growing focus on advanced treatment with better accessibility will create profitable growth prospects. For instance, the Affordable Care Act is implemented to help nearly 40 million uninsured Americans to gain access to healthcare services.
Similarly, England provides free health services for people. The National Health Service (NHS) provides preventive medicines, primary care, and hospital services to every person in the country. For instance, in 2018 radical changes were introduced in NHS that will allow social care leaders to formally devise care for individual patients, which will be increasingly made available away from hospitals. These developments aimed at making healthcare better accessible will present a conducive environment for respiratory device sales.
Likewise, the universal healthcare system in Japan is famous for providing low-cost healthcare policies to people. As per OCED, Japan’s healthcare is focusing on improving the quality of care as well as on controlling costs. Favorable regulatory policies will further continue steady growth in sales through the forecast period.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Opportunities Abound in COPD Treatment
According to Future Market Insights, Inc, the demand for respiratory devices will be higher for the treatment of COPD. While the disease indication will continue leading, the COPD segment is anticipated to grow rapidly in the forecast year. Apart from the rising prevalence of COPD, increasing healthcare expenditure around the world will also be expected to expand the growth of the respiratory devices market.
According to the Australian Institute of Health and Welfare, from 2014 to 15, 1 in 20 Australians who were 45 or older were suffering from COPD. Additionally, the World Health Organization (WHO) reports that around 251 million COPD cases were found globally in 2016. Additionally, according to the National Health Service (NHS), 1.2 million people in the United Kingdom currently have COPD. With the incidence of the disease forecast to rise, the demand for nebulizers to treat COPD is expected to surge in the next few years.
Comparative view of the Respiratory Devices Market
Respiratory Devices Market:
| Attributes | Respiratory Devices Market |
|---|---|
|
CAGR (2023 to 2033) |
8.7% |
|
Market Value (2033) |
US$ 31.08 Billion |
|
Growth Factor |
The key causes propelling the market's expansion include the rising incidence of respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, and tuberculosis |
|
Opportunity |
Apart from the rising prevalence of COPD, increasing healthcare expenditure around the world will also be expected to expand the growth of the respiratory devices market. |
Respiratory Pathogen Testing Kits Market:
| Attributes | Respiratory Pathogen Testing Kits Market |
|---|---|
|
CAGR (2023 to 2033) |
6.1% |
|
Market Value (2033) |
US$ 4.88 Billion |
|
Growth Factor |
Due to an increase in the prevalence of respiratory illnesses worldwide, the market for respiratory pathogen kits is expected to grow quickly. |
|
Opportunity |
The market is subject to adjustments based on legislative requirements, product adoption rates, and industry and macro dynamics. |
Respiratory Measurement Devices Market:
| Attributes | Respiratory Measurement Devices Market |
|---|---|
|
CAGR (2023 to 2033) |
5.1% |
|
Market Value (2033) |
US$ 10.13 Billion |
|
Growth Factor |
The rising senior population, the prevalence of sleep apnea, and the need for non-invasive, painless testing are all predicted to boost the market. |
|
Opportunity |
The market for respiratory monitoring devices is always expanding with new technologies that will improve patient comfort and increase monitoring accuracy. |
Respiratory Devices Market - Country-wise Insight
Advanced Healthcare Infrastructure assist the United States to Take a Big Leap in the Global Market
Future Market Insights, Inc has projected the United States to remain one of the most lucrative respiratory device markets throughout the forecast period. One of the key factors supporting expansion is the region’s high healthcare spending. As per CMS’ preliminary forecasts by the Office of the Actuary, the total healthcare expenditure in the United States alone is likely to increase at 5.4% between 2019 and 2028, outpacing the country’s GDP by 4.3%.
Furthermore, the United States remains one of the largest markets for medical devices globally, which invariably makes it a lucrative pocket for respiratory device manufacturers. According to Select United States of America, the medical devices market in the United States forecasted 40% of the global market in 2017. By 2023, it is projected to reach 2033 Billion US$. As per the Centers for Medicare & Medicaid Services (CMS), retail spending for durable medical equipment in the United States stood at 54.4 Billion US$ in 2017. It is projected to increase in the coming years, which is indicative of the remarkable scope for expansion it will offer to respiratory device companies.
| Attribute | Details |
|---|---|
|
United States Market Size (US$Million/Billion) by End of Forecast Period (2033) |
US$ 24.0 Billion |
|
United States Market Absolute Dollar Growth (US$ Million/Billion) |
US$ 15.4 Billion |
|
CAGR % 2017 to 2022 |
8.7% |
|
CAGR % 2023 to End of Forecast (2033) |
10.9% |
The United Kingdom’s Regulatory Authorities to Focus On Healthcare Expenditures
The adoption of respiratory devices is expected to rise considerably across hospitals and healthcare facilities in countries across the United Kingdom As a result of efforts by various government organizations such as the European Academy of Allergy & Clinical Immunology to spread awareness about COPD and other respiratory diseases such as asthma, the demand for respiratory devices is believed to surge. As per Future Market Insights, Inc Europe is the second-leading market, a position it is likely to hold on to through the projected period.
According to the University of Edinburgh research, in England COPD treatment costs is likely to exceed 2.5 billion euro by 2030. This is indicative of increased health spending on the treatment of respiratory ailments, which represents the scope for expansion in the United Kingdom
| Attribute | Details |
|---|---|
|
United Kingdom Market Size (US$Million/Billion) by End of Forecast Period (2033) |
US$ 2.5 Billion |
|
United Kingdom Market Absolute Dollar Growth (US$ Million/Billion) |
US$ 1.5 Billion |
|
CAGR % 2017 to 2022 |
12.5% |
|
CAGR % 2023 to End of Forecast (2033) |
10.9% |
Conducive Reimbursement Policies and Regulatory Scenario are Presenting Attractive Growth Opportunities in Germany
The Federal Statistical Office has reported that healthcare spending in Germany rose by 4% in 2018 from 2017. In 2018, Germany spends 11.7% of its GDP on healthcare expenditures. Moreover, healthcare spending was anticipated to increase to 407.4 billion Euros by the end of 2019, presenting a lucrative landscape for the expansion of respiratory devices.
Also, the presence of companies such as Drägerwerk AG & Co. KGaA is supporting the expansion in Germany. The company makes affordable and effective technology possible to produce Seattle PAP, a patented innovation for the treatment of respiratory distress symptoms in babies and children. Besides this, the company has been investing significantly in expansion efforts. Growth strategies adopted by these companies are expected to aid the expansion in Germany.
Since 2009, health insurance has been made mandatory for all citizens of the country. According to NCBI, a total of 70 million people, which roughly covers 85% of the population are covered by statutory health insurance. Another 11% population of Germany is covered by substitutive private health insurance.
| Attribute | Details |
|---|---|
|
Germany Market Size (US$Million/Billion) by End of Forecast Period (2033) |
US$ 3.4 Billion |
|
Germany Market Absolute Dollar Growth (US$ Million/Billion) |
US$ 2.2 Billion |
|
CAGR % 2017 to 2022 |
10.7% |
|
CAGR % 2023 to End of Forecast (2033) |
12.1% |
What is the Surging Demand for Respiratory Devices in China?
Through the forecast years, growth in South Asia is expected to accelerate. . The World Health Organization has reported that in 2015 almost 3.17 million people across the world died due to COPD, and 90% of COPD deaths were recorded in low and middle-income countries, including China.
A nationwide survey conducted in China revealed that about 8.6% of adults in China are suffering from COPD in 2018. Based on results revealed in the Global Burden of Disease Study, COPD was the fourth-leading cause of death in the country in 2013. These figures are indicative of opportunities for wider penetration in China, subsequently South Asia.
| Attribute | Details |
|---|---|
|
China Market Size (US$Million/Billion) by End of Forecast Period (2033) |
US$ 2.9 Billion |
|
China Market Absolute Dollar Growth (US$ Million/Billion) |
US$ 1.6 Billion |
|
CAGR % 2017 to 2022 |
9.9% |
|
CAGR % 2023 to End of Forecast (2033) |
8.2% |
Healthcare Technology to hit India Market Towards Growth Trajectory
Due to rising rates of respiratory conditions like COPD, TB, asthma, and sleep apnea, as well as technical developments and expanding uses in home care settings, the Indian market for respiratory devices is predicted to expand quickly. The country's rapid urbanization and heavy pollution have increased the prevalence of respiratory illnesses in India.
| Attribute | Details |
|---|---|
|
India Market Size (US$Million/Billion) by End of Forecast Period (2033) |
US$ 3.4 Billion |
|
India Market Absolute Dollar Growth (US$ Million/Billion) |
US$ 2.0 Billion |
|
CAGR % 2017 to 2022 |
13.0% |
|
CAGR % 2023 to End of Forecast (2033) |
10.2% |
Respiratory Devices Market - Category-wise Insights
What’s the Market Share of Positive Airway Pressure (PAP) Devices?
The positive airway pressure (PAP) devices segment will continue to account for over half of the global share among products through the forecast period. According to Future Market Insights, Inc, the segment is expected to hold a little above 35% of the market, in terms of product type, by the end of 2031. Positive airway pressure (PAP) devices offer greater precision and straightforward usage, which are the leading causes behind the dominance of the segment.
Positive Airway Pressure (PAP) devices reduce daytime sleepiness by keeping airway passages open. Also, it possibly reduces other sleep apnea-related health problems such as high blood pressure, diabetes, heart disease, and stroke.
| Product Type | Positive Airway Pressure Devices |
|---|---|
|
CAGR % 2017 to 2022 |
11.1% |
|
CAGR % 2023 to End of Forecast (2033) |
10.6% |
How Much Do Hospitals Contribute to Respiratory Devices Sales?
Driven by the higher footprint of patients, hospitals have continued accounting for the leading share in the Respiratory Devices Market among end users. Through the course of the forecast period, hospitals are expected to record high demand for respiratory devices. The outbreak of COVID-19 has been crucial in pushing growth in the segment. For instance, several COVID-19 patients are seen to experience mild to moderate respiratory illness, which makes respiratory devices crucial for administering patient care. According to Future Market Insights, Inc hospitals as end users are likely to account for above 42% of the market by the end of 2031.
| Top End User | Hospitals |
|---|---|
|
CAGR % 2017 to 2022 |
10.1% |
|
CAGR % 2023 to End of Forecast (2033) |
8.6% |
Startup Ecosystem
Hospitech Reigns
Israeli startup producing medical devices Hospitech Respiration was established in 2006 and creates airway management products for patients with mechanical ventilation.
Due to the Covid-19 epidemic, the AnapnoGuard system in particular has become more well-known in 2020.
The device offers ventilated patients-controlled regulation of the airway cuff pressure and automated evacuation of subglottic secretions, preventing infection or lung injury. It has already acquired United States FDA authorization and a CE mark for usage in Europe.
Circadia Health Medical Devices
Circadia Health was founded in 2016 and, despite doing much of its business in the United States, is headquartered in London, England.
Its AI-powered Circadia C100 device is placed at a patient's bedside and allows for continuous, remote, medical-grade monitoring of their breathing. It received a 510(k) notification from the FDA in June 2020.
Competitive Landscape
Leading players are focusing on strategic acquisitions to strengthen their product portfolio. For instance, Masimo Corporation acquired TNI medical AG (TNI) for patients suffering from respiratory insufficiency to provide innovative pulmonary care therapy in 2020. Similarly, Resmed Inc. 2019 completed the acquisition of HB Healthcare (HBH) and Propeller Health to provide connected health solutions for people living with chronic obstructive pulmonary disease (COPD) and other respiratory conditions like asthma.
Companies operating in the respiratory devices market are focusing on strategic collaborations to address the requirements of an expanding patient pool. For instance, In June 2020, Medtronic plc entered into a partnership with Foxconn Industrial Internet to begin manufacturing Medtronic’s Puritan Bennett 560 (PB560) ventilators in the United States.
Similarly, Smith’s Medical has signed a distribution partnership with Medline Industries for the distribution of the Portex acapella, a vibratory PEP therapy device to focus on the non-acute and home care channels in 2019.
There is ample focus on innovations and USFDA approval among players. Besides aiming at a competitive advantage, key players are focusing on the expansion of their global footprint as they expect approvals from regulatory authorities. For instance, In 2019, Masimo corporation got USFDA approval for Neonatal RD SET Pulse Oximetry Sensors with improved accuracy Specifications, O3 Regional Oximetry for use on neonatal and infant patients, Radius PPG, a first tetherless SET pulse oximetry sensor solution. Likewise, Masimo corporations Rad-G Pulse Oximeter got USFDA approval in 2020 to treat respiratory disorders.
Most of the companies are focusing on new product launches with advanced technology coupled with new ventilation solution that provides respiratory support to neonates, infants, pediatrics, and adults. For instance, in 2019 ResMed Inc. launched an automated ResMed ReSupply solution to increase long-term therapy adherence and improve the satisfaction of patients suffering from sleep apnea disorders.
Some of the leading companies operating in the Respiratory Devices Market are
- Massimo Corporation
- Teleflex Incorporated
- Fisher & Paykel Healthcare Limited
- ResMed Inc.
- Hamilton Medical AG
- Medtronic plc.
- Koninklijke Philips N.V.
- Smith’s Medical
- General Electric Healthcare Limited
- Drägerwerk AG & Co. KGaA
- Inogen Inc.
Scope of Report
| Attribute | Details |
|---|---|
|
Forecast Period |
2023 to 2033 |
|
Historical Data Available for |
2018 to 2022 |
|
Market Analysis |
US$ Billion for Value |
|
Key Countries Covered |
United States, Canada, Germany, United Kingdom, France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, Gulf Cooperation Council Countries, Turkey, Northern Africa, and South Africa |
|
Key Segments Covered |
|
|
Key Companies Profiled |
|
|
Report Coverage |
Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
|
Customization & Pricing |
Available upon Request |
Respiratory Devices Market
By Product:
- Respiratory Consumables
- Respiratory Mask
- Nasal Cannulas
- Oxygen Tubing Sets
- Breathing Filters
- Nebulizers
- Compressed Jet Nebulizers
- Ultrasonic Nebulizers
- Oxygen Concentrators
- Home Oxygen Concentrators
- Portable Oxygen
- Concentrators`
- Positive Airway Pressure (PAP) Devices
- Polysomnography Devices
- Ambulatory PSG Devices
- Clinical PSG Devices
- Pulse Oximeters
- Mechanical Ventilators
- Spirometers
By End Users:
- Hospitals
- Ambulatory Surgical Centers
- Clinics
- Long Term Care Centers
- Others
By Region:
- North America
- Latin America
- Europe
- South Asia & Pacific
- East Asia
- Middle East & Africa (MEA)
Frequently Asked Questions
How is the Respiratory Devices Market Growing?
The respiratory devices market is predicted to grow at 8.7% CAGR from 2023 to 2033.
What Drives the Respiratory Devices Market?
High prevalence of chronic diseases and growing geriatric population
What is the Future Scope of Growth for the Respiratory Devices Market?
The respiratory devices market is expected to surpass US$ 55.9 billion by 2033.
What is the Current Respiratory Devices Market Size?
The respiratory devices market size is anticipated to be US$ 24.2 billion in 2023.
Table of Content
1. Executive Summary | Respiratory Devices Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ million) Analysis, 2017 to 2022 4.2. Current and Future Market Size Value (US$ million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ million) Analysis By Product Type, 2017 to 2022 5.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Product Type, 2023 to 2033 5.3.1. Respirtaory Consumables 5.3.1.1. Respiratory Mask 5.3.1.2. Nasal Cannulas 5.3.1.3. Tracheostomy Tubes and Oxygen Tubes 5.3.1.4. Other Accessories and Consumables 5.3.2. Nebulizers 5.3.2.1. Compressed Jet Nebulizers 5.3.2.2. Ultrasonic Nebulizers 5.3.2.3. Mesh Nebulizers 5.3.3. Oxygen Concentrators 5.3.3.1. Home Oxygen Concentrators 5.3.3.2. Portable Oxygen Concentrators 5.3.4. Positive Airway Pressure Devices 5.3.5. Polysomillionography Devices 5.3.5.1. Ambulatory PSG 5.3.5.2. Clinical PSG 5.3.6. Pulse Oximeters 5.3.7. Mechanical Ventilators 5.3.8. Spirometers 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017 to 2022 5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033 6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ million) Analysis By End User, 2017 to 2022 6.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By End User, 2023 to 2033 6.3.1. Hospitals 6.3.2. Ambilatory Surgical Centers 6.3.3. Clinics 6.3.4. Long Term Care Centers 6.3.5. Others 6.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2022 6.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033 7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ million) Analysis By Region, 2017 to 2022 7.3. Current Market Size Value (US$ million) Analysis and Forecast By Region, 2023 to 2033 7.3.1. North America 7.3.2. Latin America 7.3.3. Western Europe 7.3.4. Eastern Europe 7.3.5. Asia Pacific excluding Japan (APEJ) 7.3.6. Japan 7.3.7. Middle East and Africa (MEA) 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 8.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022 8.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033 8.2.1. By Country 8.2.1.1. The USA 8.2.1.2. Canada 8.2.2. By Product Type 8.2.3. By End User 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Product Type 8.3.3. By End User 8.4. Key Takeaways 9. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022 9.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Product Type 9.2.3. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product Type 9.3.3. By End User 9.4. Key Takeaways 10. Western Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022 10.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. France 10.2.1.3. The United Kingdom 10.2.1.4. Italy 10.2.1.5. Spain 10.2.1.6. Rest of Western Europe 10.2.2. By Product Type 10.2.3. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product Type 10.3.3. By End User 10.4. Key Takeaways 11. Eastern Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022 11.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Russia 11.2.1.2. Poland 11.2.1.3. Rest of Eastern Europe 11.2.2. By Product Type 11.2.3. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product Type 11.3.3. By End User 11.4. Key Takeaways 12. APEJ Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022 12.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. China 12.2.1.2. India 12.2.1.3. Australia & New Zealand 12.2.1.4. ASEAN 12.2.1.5. Rest of APEJ 12.2.2. By Product Type 12.2.3. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product Type 12.3.3. By End User 12.4. Key Takeaways 13. Japan Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022 13.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.2. By Product Type 13.2.3. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product Type 13.3.3. By End User 13.4. Key Takeaways 14. MEA Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022 14.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. GCC Countries 14.2.1.2. South Africa 14.2.1.3. Rest of MEA 14.2.2. By Product Type 14.2.3. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product Type 14.3.3. By End User 14.4. Key Takeaways 15. Key Countries Market Analysis 15.1. The USA 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2022 15.1.2.1. By Product Type 15.1.2.2. By End User 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2022 15.2.2.1. By Product Type 15.2.2.2. By End User 15.3. Brazil 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2022 15.3.2.1. By Product Type 15.3.2.2. By End User 15.4. Mexico 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2022 15.4.2.1. By Product Type 15.4.2.2. By End User 15.5. Germany 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2022 15.5.2.1. By Product Type 15.5.2.2. By End User 15.6. France 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2022 15.6.2.1. By Product Type 15.6.2.2. By End User 15.7. The United Kingdom 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2022 15.7.2.1. By Product Type 15.7.2.2. By End User 15.8. Italy 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2022 15.8.2.1. By Product Type 15.8.2.2. By End User 15.9. Spain 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2022 15.9.2.1. By Product Type 15.9.2.2. By End User 15.10. Russia 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2022 15.10.2.1. By Product Type 15.10.2.2. By End User 15.11. Poland 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2022 15.11.2.1. By Product Type 15.11.2.2. By End User 15.12. China 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2022 15.12.2.1. By Product Type 15.12.2.2. By End User 15.13. India 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2022 15.13.2.1. By Product Type 15.13.2.2. By End User 15.14. Australia & New Zealand 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2022 15.14.2.1. By Product Type 15.14.2.2. By End User 15.15. Japan 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2022 15.15.2.1. By Product Type 15.15.2.2. By End User 15.16. GCC Countries 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2022 15.16.2.1. By Product Type 15.16.2.2. By End User 15.17. South Africa 15.17.1. Pricing Analysis 15.17.2. Market Share Analysis, 2022 15.17.2.1. By Product Type 15.17.2.2. By End User 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Product Type 16.3.3. By End User 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. Massimo Corporation 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.2. Teleflex Incorporated 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.3. Fisher & Paykel Healthcare Limited 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.4. ResMed Inc. 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.5. Hamilton Medical AG 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.6. Medtronic plc. 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.7. Koninklijke Philips N.V. 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.8. Smith’s Medical 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segments 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.9. General Electric Healthcare Limited 17.1.9.1. Overview 17.1.9.2. Product Portfolio 17.1.9.3. Profitability by Market Segments 17.1.9.4. Sales Footprint 17.1.9.5. Strategy Overview 17.1.9.5.1. Marketing Strategy 17.1.10. Drägerwerk AG & Co. KGaA 17.1.10.1. Overview 17.1.10.2. Product Portfolio 17.1.10.3. Profitability by Market Segments 17.1.10.4. Sales Footprint 17.1.10.5. Strategy Overview 17.1.10.5.1. Marketing Strategy 17.1.11. Inogen Inc. 17.1.11.1. Overview 17.1.11.2. Product Portfolio 17.1.11.3. Profitability by Market Segments 17.1.11.4. Sales Footprint 17.1.11.5. Strategy Overview 17.1.11.5.1. Marketing Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market Value (US$ million) Forecast by Region, 2017 to 2033 Table 2: Global Market Value (US$ million) Forecast by Product Type, 2017 to 2033 Table 3: Global Market Value (US$ million) Forecast by End User, 2017 to 2033 Table 4: North America Market Value (US$ million) Forecast by Country, 2017 to 2033 Table 5: North America Market Value (US$ million) Forecast by Product Type, 2017 to 2033 Table 6: North America Market Value (US$ million) Forecast by End User, 2017 to 2033 Table 7: Latin America Market Value (US$ million) Forecast by Country, 2017 to 2033 Table 8: Latin America Market Value (US$ million) Forecast by Product Type, 2017 to 2033 Table 9: Latin America Market Value (US$ million) Forecast by End User, 2017 to 2033 Table 10: Western Europe Market Value (US$ million) Forecast by Country, 2017 to 2033 Table 11: Western Europe Market Value (US$ million) Forecast by Product Type, 2017 to 2033 Table 12: Western Europe Market Value (US$ million) Forecast by End User, 2017 to 2033 Table 13: Eastern Europe Market Value (US$ million) Forecast by Country, 2017 to 2033 Table 14: Eastern Europe Market Value (US$ million) Forecast by Product Type, 2017 to 2033 Table 15: Eastern Europe Market Value (US$ million) Forecast by End User, 2017 to 2033 Table 16: APEJ Market Value (US$ million) Forecast by Country, 2017 to 2033 Table 17: APEJ Market Value (US$ million) Forecast by Product Type, 2017 to 2033 Table 18: APEJ Market Value (US$ million) Forecast by End User, 2017 to 2033 Table 19: Japan Market Value (US$ million) Forecast by Country, 2017 to 2033 Table 20: Japan Market Value (US$ million) Forecast by Product Type, 2017 to 2033 Table 21: Japan Market Value (US$ million) Forecast by End User, 2017 to 2033 Table 22: MEA Market Value (US$ million) Forecast by Country, 2017 to 2033 Table 23: MEA Market Value (US$ million) Forecast by Product Type, 2017 to 2033 Table 24: MEA Market Value (US$ million) Forecast by End User, 2017 to 2033
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Market Value (US$ million) by Product Type, 2023 to 2033 Figure 2: Global Market Value (US$ million) by End User, 2023 to 2033 Figure 3: Global Market Value (US$ million) by Region, 2023 to 2033 Figure 4: Global Market Value (US$ million) Analysis by Region, 2017 to 2033 Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033 Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033 Figure 7: Global Market Value (US$ million) Analysis by Product Type, 2017 to 2033 Figure 8: Global Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 9: Global Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 10: Global Market Value (US$ million) Analysis by End User, 2017 to 2033 Figure 11: Global Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 12: Global Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 13: Global Market Attractiveness by Product Type, 2023 to 2033 Figure 14: Global Market Attractiveness by End User, 2023 to 2033 Figure 15: Global Market Attractiveness by Region, 2023 to 2033 Figure 16: North America Market Value (US$ million) by Product Type, 2023 to 2033 Figure 17: North America Market Value (US$ million) by End User, 2023 to 2033 Figure 18: North America Market Value (US$ million) by Country, 2023 to 2033 Figure 19: North America Market Value (US$ million) Analysis by Country, 2017 to 2033 Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 22: North America Market Value (US$ million) Analysis by Product Type, 2017 to 2033 Figure 23: North America Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 24: North America Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 25: North America Market Value (US$ million) Analysis by End User, 2017 to 2033 Figure 26: North America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 27: North America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 28: North America Market Attractiveness by Product Type, 2023 to 2033 Figure 29: North America Market Attractiveness by End User, 2023 to 2033 Figure 30: North America Market Attractiveness by Country, 2023 to 2033 Figure 31: Latin America Market Value (US$ million) by Product Type, 2023 to 2033 Figure 32: Latin America Market Value (US$ million) by End User, 2023 to 2033 Figure 33: Latin America Market Value (US$ million) by Country, 2023 to 2033 Figure 34: Latin America Market Value (US$ million) Analysis by Country, 2017 to 2033 Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 37: Latin America Market Value (US$ million) Analysis by Product Type, 2017 to 2033 Figure 38: Latin America Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 40: Latin America Market Value (US$ million) Analysis by End User, 2017 to 2033 Figure 41: Latin America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 42: Latin America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 43: Latin America Market Attractiveness by Product Type, 2023 to 2033 Figure 44: Latin America Market Attractiveness by End User, 2023 to 2033 Figure 45: Latin America Market Attractiveness by Country, 2023 to 2033 Figure 46: Western Europe Market Value (US$ million) by Product Type, 2023 to 2033 Figure 47: Western Europe Market Value (US$ million) by End User, 2023 to 2033 Figure 48: Western Europe Market Value (US$ million) by Country, 2023 to 2033 Figure 49: Western Europe Market Value (US$ million) Analysis by Country, 2017 to 2033 Figure 50: Western Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 51: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 52: Western Europe Market Value (US$ million) Analysis by Product Type, 2017 to 2033 Figure 53: Western Europe Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 54: Western Europe Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 55: Western Europe Market Value (US$ million) Analysis by End User, 2017 to 2033 Figure 56: Western Europe Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 57: Western Europe Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 58: Western Europe Market Attractiveness by Product Type, 2023 to 2033 Figure 59: Western Europe Market Attractiveness by End User, 2023 to 2033 Figure 60: Western Europe Market Attractiveness by Country, 2023 to 2033 Figure 61: Eastern Europe Market Value (US$ million) by Product Type, 2023 to 2033 Figure 62: Eastern Europe Market Value (US$ million) by End User, 2023 to 2033 Figure 63: Eastern Europe Market Value (US$ million) by Country, 2023 to 2033 Figure 64: Eastern Europe Market Value (US$ million) Analysis by Country, 2017 to 2033 Figure 65: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 66: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 67: Eastern Europe Market Value (US$ million) Analysis by Product Type, 2017 to 2033 Figure 68: Eastern Europe Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 69: Eastern Europe Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 70: Eastern Europe Market Value (US$ million) Analysis by End User, 2017 to 2033 Figure 71: Eastern Europe Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 72: Eastern Europe Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 73: Eastern Europe Market Attractiveness by Product Type, 2023 to 2033 Figure 74: Eastern Europe Market Attractiveness by End User, 2023 to 2033 Figure 75: Eastern Europe Market Attractiveness by Country, 2023 to 2033 Figure 76: APEJ Market Value (US$ million) by Product Type, 2023 to 2033 Figure 77: APEJ Market Value (US$ million) by End User, 2023 to 2033 Figure 78: APEJ Market Value (US$ million) by Country, 2023 to 2033 Figure 79: APEJ Market Value (US$ million) Analysis by Country, 2017 to 2033 Figure 80: APEJ Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 81: APEJ Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 82: APEJ Market Value (US$ million) Analysis by Product Type, 2017 to 2033 Figure 83: APEJ Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 84: APEJ Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 85: APEJ Market Value (US$ million) Analysis by End User, 2017 to 2033 Figure 86: APEJ Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 87: APEJ Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 88: APEJ Market Attractiveness by Product Type, 2023 to 2033 Figure 89: APEJ Market Attractiveness by End User, 2023 to 2033 Figure 90: APEJ Market Attractiveness by Country, 2023 to 2033 Figure 91: Japan Market Value (US$ million) by Product Type, 2023 to 2033 Figure 92: Japan Market Value (US$ million) by End User, 2023 to 2033 Figure 93: Japan Market Value (US$ million) by Country, 2023 to 2033 Figure 94: Japan Market Value (US$ million) Analysis by Country, 2017 to 2033 Figure 95: Japan Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 96: Japan Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 97: Japan Market Value (US$ million) Analysis by Product Type, 2017 to 2033 Figure 98: Japan Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 99: Japan Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 100: Japan Market Value (US$ million) Analysis by End User, 2017 to 2033 Figure 101: Japan Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 102: Japan Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 103: Japan Market Attractiveness by Product Type, 2023 to 2033 Figure 104: Japan Market Attractiveness by End User, 2023 to 2033 Figure 105: Japan Market Attractiveness by Country, 2023 to 2033 Figure 106: MEA Market Value (US$ million) by Product Type, 2023 to 2033 Figure 107: MEA Market Value (US$ million) by End User, 2023 to 2033 Figure 108: MEA Market Value (US$ million) by Country, 2023 to 2033 Figure 109: MEA Market Value (US$ million) Analysis by Country, 2017 to 2033 Figure 110: MEA Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 111: MEA Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 112: MEA Market Value (US$ million) Analysis by Product Type, 2017 to 2033 Figure 113: MEA Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 114: MEA Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 115: MEA Market Value (US$ million) Analysis by End User, 2017 to 2033 Figure 116: MEA Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 117: MEA Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 118: MEA Market Attractiveness by Product Type, 2023 to 2033 Figure 119: MEA Market Attractiveness by End User, 2023 to 2033 Figure 120: MEA Market Attractiveness by Country, 2023 to 2033
Recommendations
Explore Healthcare Insights
View Reports
